Who are NEXGEL, Inc.'s main suppliers?

NEXGEL, Inc. (NXGL) key suppliers include: ALERE-FINANCIAL-PARTNERS, CELULARITY-INC, PALLADIUM-CAPITAL-GROUP, CELULARITY, MR-KIESER and 1 more. View the full supplier network at chainsifter.com/chain/NXGL.

Who are NEXGEL, Inc.'s major customers?

NEXGEL, Inc. (NXGL) key customers include: STADA-ARZNEIMITTEL-AG, CG-LABORATORIES-INC, Johnson & Johnson, Johnson & Johnson, United Parcel Service, Inc. and 7 more. View the full customer network at chainsifter.com/chain/NXGL.

What sector is NEXGEL, Inc. in?

NEXGEL, Inc. (NXGL) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NEXGEL, Inc. Supplier List (NXGL): 6 Verified Suppliers

6Suppliers

12Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

NEXGEL, Inc. (NXGL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

21Total relationships

6Distinct source URLs

11High confidence

0.787Average confidence

2026-09-14Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

NEXGEL, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ALERE-FINANCIAL-PARTNERS	ALERE-FINANCIAL-PARTNERS	92%	Alere Financial Partners, a division of Cova Capital Partners, LLC, acted as placement agent in connection with the Offering
CELULARITY-INC	CELULARITY-INC	92%	Celularity agreed to sell to the Company assets related to the portfolio
PALLADIUM-CAPITAL-GROUP	PALLADIUM-CAPITAL-GROUP	92%	Palladium Capital Group the 'Placement Agent' acted as the Company's placement agent with respect to the Convertible Notes
CELULARITY	CELULARITY	90%	The Company may be required to make contingent milestone payments of up to $ 17.5 million to Celularity upon the achievement of specified commercial milestones.
MR-KIESER	MR-KIESER	90%	the Company entered into a Securities Purchase Agreement with Mr. Kieser, pursuant to which Mr. Kieser was issued an unsecured convertible promissory note
SEQUENCE-LIFESCIENCE-INC	SEQUENCE-LIFESCIENCE-INC	90%	the Company entered into certain Securities Purchase Agreements with Sequence LifeScience, Inc. pursuant to which Sequence was issued an unsecured convertible promissory notes

NEXGEL, Inc. Customers

Ticker	Name	Confidence	Evidence
STADA-ARZNEIMITTEL-AG	STADA-ARZNEIMITTEL-AG	92%	The expansion included a $ 1 million advance from STADA to the Company in non-dilutive capital to support product launches and marketing efforts under the Master Distribution Agreement between the parties
CG-LABORATORIES-INC	CG-LABORATORIES-INC	85%	zing color and texture. Our joint venture with CG Laboratories, Inc. called CG Converting and Packaging, LLC, which is located in Granbury, Texas in which we own a 50% interest, allowing us to expand…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from NXGL graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from NXGL graph: Reciprocal relationship from JNJ grap…
JNJ	Johnson & Johnson	72%	. To our knowledge, NexGel is one of two manufacturers using electron beam technology for high performance hydrogels for the wound care, cosmetic and drug delivery industries. However, the other manu…
UPS	United Parcel Service, Inc.	72%	. Hydrogel dressings have long been used for treating wounds and burns. Clinical trials have demonstrated the benefits of moist wound healing versus traditional dressings. Some of these benefits incl…
UPS	United Parcel Service, Inc.	72%	Reciprocal relationship from UPS graph: Reciprocal relationship from NXGL graph: Reciprocal relationship from UPS graph: Reciprocal relationship from NXGL graph: Reciprocal relationship from UPS grap…
ACHIEVING-CONSULTING-EXCELLENCE-LLC	ACHIEVING-CONSULTING-EXCELLENCE-LLC	62%	d will be applied against eligible project costs as incurred in accordance with the terms of the Master Distribution Agreement, as amended. License agreement Under the License Agreement described in …
AQUAMED-TECHNOLOGIES-INC	AQUAMED-TECHNOLOGIES-INC	62%	y served as a contract manufacturer, supplying our gels to third parties who incorporate them into their own products. Beginning in 2020, we created two new lines of business for the Company. First, …
C-G-LABORATORIES-INC	C-G-LABORATORIES-INC	62%	d will be applied against eligible project costs as incurred in accordance with the terms of the Master Distribution Agreement, as amended. License agreement Under the License Agreement described in …
PACKAGING-LLC	PACKAGING-LLC	62%	and Packaging, LLC, which is located in Granbury, Texas in which we own a 50% interest, allowing us to expand our ability to deliver finished goods to our growing customer base. 19 Table of Contents …
PRESENTATION-NEXGEL-INC	PRESENTATION-NEXGEL-INC	62%	o decrease in cash and $ 741 relates to increase in restricted cash Supplemental Non-cash Investing and Financing Activities Warrants issued in conjunction with investment in NexgelRx $ 87 $ 200 Addi…
SEMMENS-ONLINE-PTY-LTD	SEMMENS-ONLINE-PTY-LTD	62%	l CG Labs Total Revenues 6,631 2,057 8,688 Cost of sales 4,209 1,731 5,940 Advertising, marketing and amazon fees 2,220 - 2,220 General and administrative 3,409 595 4,004 Total Selling, general and a…

NEXGEL, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
NXGL-DEBT-11450	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2026-03-31.
NXGL-DEBT-11449	Warrants outstanding: 125000	90%	xbrl warrant detail from xbrl 2025-12-31.
NXGL-DEBT	Debt stack $3.1M	90%	Market cache reports total debt of $3.1M.

NEXGEL, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NEXGEL, Inc..

NEXGEL, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for NEXGEL, Inc..

NEXGEL, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ABBV	AbbVie Inc.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ACIU	AC Immune SA	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ALGN	Align Technology, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
AORT	Artivion, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
ALC	Alcon Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

NEXGEL, Inc. Supply Chain